Search Results for "Juvisync"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Juvisync. Results 1 to 3 of 3 total matches.
See also: simvastatin, sitagliptin
Sitagliptin and Simvastatin (Juvisync)
The Medical Letter on Drugs and Therapeutics • Nov 14, 2011 (Issue 1377)
Sitagliptin and Simvastatin (Juvisync) ...
The FDA has approved Juvisync (Merck), a fixed-dose
combination of the antihyperglycemic DPP-4 inhibitor
sitagliptin (Januvia) and the HMG-CoA reductase
inhibitor simvastatin (Zocor, and others).
Drug Interaction: Dabigatran (Pradaxa) and Statins
The Medical Letter on Drugs and Therapeutics • Jan 30, 2017 (Issue 1513)
. Center for Drug Evaluation and Research. Juvisync (sitagliptin +
simvastatin tablets). Clinical ...
The results of a recently published study suggest that
taking the oral direct thrombin inhibitor dabigatran
etexilate (Pradaxa) with either simvastatin (Zocor, and
others) or lovastatin (Altoprev, and others) increases the
risk of major hemorrhage.
Alogliptin (Nesina) for Type 2 Diabetes
The Medical Letter on Drugs and Therapeutics • May 27, 2013 (Issue 1417)
in combination with simvastatin (Juvisync).
8. A dose of 50 mg once daily is recommended in patients with a CrCl ...
The FDA has approved the dipeptidyl peptidase-4
(DPP-4) inhibitor alogliptin (Nesina – Takeda) for treatment
of type 2 diabetes. In addition to the single-ingredient
product, the FDA also approved fixed-dose
combinations of alogliptin/metformin (Kazano) and
alogliptin/pioglitazone (Oseni) for the same indication.
Alogliptin is the fourth DPP-4 inhibitor to become available
in the US. The other three – saxagliptin (Onglyza),
sitagliptin (Januvia), and linagliptin (Tradjenta) – are also
available in fixed-dose combinations with metformin.